Who will suffer from hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Podobne zapisy

• Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
  od: Ferrara, Roberto, i wsp.
  Wydane: (2018)
• Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
  od: Faure, Marjorie, i wsp.
  Wydane: (2018)
• Hyperprogressive disease in advanced cancer patients with liver metastasis treated with PD-1 inhibitors: two case reports
  od: Lin, Zhuangbin, i wsp.
  Wydane: (2020)
• Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs
  od: Kim, Kyung Hwan, i wsp.
  Wydane: (2020)
• Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
  od: Kiriu, Tatsunori, i wsp.
  Wydane: (2019)